Khue Bui-Diem, Nguyen Van Tho, Thu Nguyen-Binh, Quynh Doan-Truc, Hoang Kim Tu Trinh, Diem D K Truong, Kieu-Minh Le, Lam Phung Khanh, Sy Duong-Quy
{"title":"Melatonin and Cortisol Concentration Before and After CPAP Treatment of Obstructive Sleep Apnea.","authors":"Khue Bui-Diem, Nguyen Van Tho, Thu Nguyen-Binh, Quynh Doan-Truc, Hoang Kim Tu Trinh, Diem D K Truong, Kieu-Minh Le, Lam Phung Khanh, Sy Duong-Quy","doi":"10.2147/NSS.S553499","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>This study investigated changes in salivary melatonin and cortisol concentrations before and after Continuous Positive Airway Pressure (CPAP) therapy in patients with OSA. Underlying these hormonal changes is a key mechanism involving dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis and circadian rhythm.</p><p><strong>Patients and methods: </strong>A prospective before-and-after study was conducted on 59 adults with OSA, of whom 27 completed an 8-week follow-up after CPAP therapy. Salivary melatonin and cortisol were measured via ELISA in morning and afternoon samples. Other habits that affect sleep were also assessed. Hormonal changes were analyzed using Wilcoxon signed-rank tests, and correlations with clinical variables were evaluated using Spearman correlation.</p><p><strong>Results: </strong>At baseline, mean melatonin concentration was 80.80 ± 52.48 pg/mL, higher in the afternoon, and mean cortisol concentrations was 7.58 ± 5.45 ng/mL, higher in the morning. After CPAP treatment, melatonin concentration decreased to 63.78 ± 39.85 pg/mL, with a reduced difference between morning and afternoon concentrations. Cortisol concentration increased slightly to 8.06 ± 8.08 ng/mL. These hormonal changes were not statistically significant (<i>p</i>>0.05). Notably, melatonin concentrations correlated negatively with tea consumption (rho = -0.43, <i>p</i><0.05) after adjustment.</p><p><strong>Conclusion: </strong>This research investigated salivary melatonin and cortisol as biomarkers for CPAP efficacy in OSA patients. Although no significant changes were detected, trends indicated reduced sleep pressure, including lower afternoon melatonin and higher cortisol levels. The substantial dropout rate limits how these results can be interpreted. More studies with larger sample sizes, longer treatment durations, and more comprehensive hormonal evaluations at various times of the day are needed to elucidate the potential significance of salivary biomarkers in understanding circadian control in OSA.</p>","PeriodicalId":18896,"journal":{"name":"Nature and Science of Sleep","volume":"17 ","pages":"2201-2212"},"PeriodicalIF":3.4000,"publicationDate":"2025-09-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12442905/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nature and Science of Sleep","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/NSS.S553499","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Purpose: This study investigated changes in salivary melatonin and cortisol concentrations before and after Continuous Positive Airway Pressure (CPAP) therapy in patients with OSA. Underlying these hormonal changes is a key mechanism involving dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis and circadian rhythm.
Patients and methods: A prospective before-and-after study was conducted on 59 adults with OSA, of whom 27 completed an 8-week follow-up after CPAP therapy. Salivary melatonin and cortisol were measured via ELISA in morning and afternoon samples. Other habits that affect sleep were also assessed. Hormonal changes were analyzed using Wilcoxon signed-rank tests, and correlations with clinical variables were evaluated using Spearman correlation.
Results: At baseline, mean melatonin concentration was 80.80 ± 52.48 pg/mL, higher in the afternoon, and mean cortisol concentrations was 7.58 ± 5.45 ng/mL, higher in the morning. After CPAP treatment, melatonin concentration decreased to 63.78 ± 39.85 pg/mL, with a reduced difference between morning and afternoon concentrations. Cortisol concentration increased slightly to 8.06 ± 8.08 ng/mL. These hormonal changes were not statistically significant (p>0.05). Notably, melatonin concentrations correlated negatively with tea consumption (rho = -0.43, p<0.05) after adjustment.
Conclusion: This research investigated salivary melatonin and cortisol as biomarkers for CPAP efficacy in OSA patients. Although no significant changes were detected, trends indicated reduced sleep pressure, including lower afternoon melatonin and higher cortisol levels. The substantial dropout rate limits how these results can be interpreted. More studies with larger sample sizes, longer treatment durations, and more comprehensive hormonal evaluations at various times of the day are needed to elucidate the potential significance of salivary biomarkers in understanding circadian control in OSA.
期刊介绍:
Nature and Science of Sleep is an international, peer-reviewed, open access journal covering all aspects of sleep science and sleep medicine, including the neurophysiology and functions of sleep, the genetics of sleep, sleep and society, biological rhythms, dreaming, sleep disorders and therapy, and strategies to optimize healthy sleep.
Specific topics covered in the journal include:
The functions of sleep in humans and other animals
Physiological and neurophysiological changes with sleep
The genetics of sleep and sleep differences
The neurotransmitters, receptors and pathways involved in controlling both sleep and wakefulness
Behavioral and pharmacological interventions aimed at improving sleep, and improving wakefulness
Sleep changes with development and with age
Sleep and reproduction (e.g., changes across the menstrual cycle, with pregnancy and menopause)
The science and nature of dreams
Sleep disorders
Impact of sleep and sleep disorders on health, daytime function and quality of life
Sleep problems secondary to clinical disorders
Interaction of society with sleep (e.g., consequences of shift work, occupational health, public health)
The microbiome and sleep
Chronotherapy
Impact of circadian rhythms on sleep, physiology, cognition and health
Mechanisms controlling circadian rhythms, centrally and peripherally
Impact of circadian rhythm disruptions (including night shift work, jet lag and social jet lag) on sleep, physiology, cognition and health
Behavioral and pharmacological interventions aimed at reducing adverse effects of circadian-related sleep disruption
Assessment of technologies and biomarkers for measuring sleep and/or circadian rhythms
Epigenetic markers of sleep or circadian disruption.